US2867616A
(en)
|
1950-05-17 |
1959-01-06 |
Syntex Sa |
7-dehydro diosgenin compounds and process for making same
|
US2867618A
(en)
|
1957-02-14 |
1959-01-06 |
Dow Chemical Co |
3, 4-dihydro-2h-1, 3-benzoxazine
|
US2826575A
(en)
|
1957-05-06 |
1958-03-11 |
Dow Chemical Co |
3, 3'-alkylenebis
|
NL128591C
(es)
|
1965-07-02 |
|
|
|
US3441649A
(en)
|
1966-08-18 |
1969-04-29 |
Univ Minnesota |
Suppression of cardiac ventricular fibrillation and cardiac arrhythmias with bretylium tosylate
|
CH482404A
(de)
|
1967-12-14 |
1969-08-15 |
Ciba Geigy |
Verwendung von Arylguanaminen zum antimikrobiellen Ausrüsten bzw. zum Schützen von Textilfasern gegen Mikroorganismen
|
US3594372A
(en)
|
1968-08-13 |
1971-07-20 |
American Home Prod |
Pyrimido(4,5-e)(1,4)oxazepin-5-ones and derivatives thereof
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
US4062881A
(en)
|
1974-07-26 |
1977-12-13 |
Cincinnati Milacron Chemicals, Inc. |
Sulfide containing tin stabilizers
|
US4230705A
(en)
|
1976-09-22 |
1980-10-28 |
American Cyanamid Company |
6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety
|
US4242515A
(en)
|
1979-03-28 |
1980-12-30 |
American Cyanamid Company |
Substituted 3-alkyl-6-phenyl-1,2,4-triazolo-[4,3-a]pyridines
|
US4244953A
(en)
|
1979-10-24 |
1981-01-13 |
American Cyanamid Company |
Substituted 6-phenyl-5,6,7,8-tetrahydro-1,2,4-triazolo-[4,3-a]pyridines
|
US4326525A
(en)
|
1980-10-14 |
1982-04-27 |
Alza Corporation |
Osmotic device that improves delivery properties of agent in situ
|
US4812565A
(en)
|
1982-09-30 |
1989-03-14 |
A. H. Robins Company, Incorporated |
Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof
|
US4567264A
(en)
|
1983-05-18 |
1986-01-28 |
Syntex (U.S.A.) Inc. |
Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry
|
US5364620A
(en)
|
1983-12-22 |
1994-11-15 |
Elan Corporation, Plc |
Controlled absorption diltiazem formulation for once daily administration
|
US4654343A
(en)
|
1985-10-31 |
1987-03-31 |
American Cyanamid Company |
N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
US4746655A
(en)
|
1987-06-10 |
1988-05-24 |
A. H. Robins Company, Incorporated |
Fused aromatic-spiropiperidine oxazepinones(and thiones)
|
US5001139A
(en)
|
1987-06-12 |
1991-03-19 |
American Cyanamid Company |
Enchancers for the transdermal flux of nivadipine
|
US4992445A
(en)
|
1987-06-12 |
1991-02-12 |
American Cyanamid Co. |
Transdermal delivery of pharmaceuticals
|
US4902514A
(en)
|
1988-07-21 |
1990-02-20 |
Alza Corporation |
Dosage form for administering nilvadipine for treating cardiovascular symptoms
|
DE4010488A1
(de)
|
1990-03-31 |
1991-10-02 |
Hoechst Ag |
Benzoxazinderivate, verfahren zu ihrer herstellung und ihre verwendung zum behandeln oder zur prophylaxe von krankheiten
|
CA2044564A1
(en)
|
1990-06-28 |
1991-12-29 |
Quirico Branca |
Amino acid derivatives
|
CN1060467A
(zh)
|
1990-09-25 |
1992-04-22 |
武田药品工业株式会社 |
1,3-苯并嗪衍生物、其生产方法和用途
|
JPH04209692A
(ja)
|
1990-12-03 |
1992-07-31 |
Asahi Glass Co Ltd |
フォトクロミック材料
|
US5246948A
(en)
|
1991-05-10 |
1993-09-21 |
Takeda Chemical Industries, Ltd. |
Pyridine derivatives, their production and use
|
AU666318B2
(en)
|
1991-06-28 |
1996-02-08 |
Smithkline Beecham Corporation |
Bicyclic fibrinogen antagonists
|
US5939412A
(en)
|
1992-06-26 |
1999-08-17 |
Smithkline Beecham Corporation |
Bicyclic fibrinogen antagonists
|
US5250679A
(en)
|
1991-10-18 |
1993-10-05 |
Genentech, Inc. |
Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
|
US5674863A
(en)
|
1991-10-18 |
1997-10-07 |
Genentech, Inc. |
Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptor
|
US5272158A
(en)
|
1991-10-29 |
1993-12-21 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
JPH061779A
(ja)
|
1992-02-06 |
1994-01-11 |
Wakamoto Pharmaceut Co Ltd |
ベンズオキサジノン誘導体
|
JPH06107647A
(ja)
|
1992-08-12 |
1994-04-19 |
Takeda Chem Ind Ltd |
1,3−ベンゾオキサジン誘導体の製造法
|
US5442055A
(en)
|
1992-11-13 |
1995-08-15 |
Tanabe Seiyaku Co., Ltd. |
Azetidinone compound and process for preparation thereof
|
US6011150A
(en)
|
1992-11-13 |
2000-01-04 |
Tanabe Seiyaku Co., Ltd. |
Azetidinone compound and process for preparation thereof
|
GB9225860D0
(en)
|
1992-12-11 |
1993-02-03 |
Smithkline Beecham Plc |
Novel treatment
|
GB9226302D0
(en)
|
1992-12-17 |
1993-02-10 |
Smithkline Beecham Plc |
Pharmaceuticals
|
US5550229A
(en)
|
1993-06-23 |
1996-08-27 |
Tanabe Seiyaku Co., Ltd. |
Alkylation process for preparing azetidinone compound and starting compound therefor
|
DE19526173A1
(de)
|
1995-07-18 |
1997-01-30 |
Hoechst Ag |
Polyfullerenaddukte, Verfahren zu ihrer regioselektiven Herstellung und deren Verwendung
|
JPH09157262A
(ja)
|
1995-12-08 |
1997-06-17 |
Tanabe Seiyaku Co Ltd |
アゼチジノン誘導体及びその合成中間体の製法
|
US5773186A
(en)
|
1996-02-19 |
1998-06-30 |
Fuji Photo Film Co., Ltd. |
Heat-sensitive recording material
|
WO1998004542A1
(en)
|
1996-07-26 |
1998-02-05 |
Nissan Chemical Industries, Ltd. |
Chroman derivatives
|
US6083986A
(en)
|
1996-07-26 |
2000-07-04 |
Icagen, Inc. |
Potassium channel inhibitors
|
GB9619492D0
(en)
|
1996-09-18 |
1996-10-30 |
Smithkline Beecham Plc |
Novel treatment
|
US5969017A
(en)
|
1996-10-31 |
1999-10-19 |
Merck & Co., Inc. |
Methods of treating or preventing cardiac arrhythmia
|
US5935945A
(en)
|
1996-10-31 |
1999-08-10 |
Merck & Co., Inc. |
Methods of treating or preventing cardiac arrhythmia
|
CA2288172A1
(en)
|
1997-04-18 |
1998-10-29 |
Smithkline Beecham P.L.C. |
A bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5ht1a, 5ht1b and 5ht1d receptor antagonistic activity
|
DE19716237A1
(de)
|
1997-04-18 |
1998-10-22 |
Basf Ag |
Substituierte Benzyloxyimino-Verbindungen
|
CA2291630A1
(en)
|
1997-05-30 |
1998-12-03 |
Tetsutaro Niizato |
Nitrogen-containing heterocyclic compounds and therapeutic agents for hyperlipidemia comprising the same
|
JP3964053B2
(ja)
|
1997-07-10 |
2007-08-22 |
三井化学株式会社 |
遷移金属化合物からなるオレフィン重合用触媒ならびに重合方法
|
BR9812051A
(pt)
|
1997-09-08 |
2000-09-26 |
Unilever Nv |
Processos para acentuar a atividade de uma oxidorredutase e para inibir a transferência de um corante têxtil a partir de um tecido tingido, composição alvejante, e, uso de um acentuador
|
GEP20032868B
(en)
|
1998-01-21 |
2003-01-27 |
Merck Sharp & Dohme |
Triazolo-Pyridazine Derivatives as Ligands for Gaba Receptors, Methods for Their Production, Pharmaceutical Compositions Containing the Same for Treatment and/or Prevention of disorders of Central Nervous System
|
US6333337B1
(en)
|
1998-01-27 |
2001-12-25 |
Icagen, Inc. |
Potassium channel inhibitors
|
EP1054877A1
(en)
|
1998-02-11 |
2000-11-29 |
Du Pont Pharmaceuticals Company |
Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
|
ZA991301B
(en)
|
1998-02-18 |
1999-09-13 |
Neurosearch As |
Glutamate receptor modulators.
|
CA2334258A1
(en)
|
1998-06-05 |
1999-12-09 |
Icagen, Inc. |
Potassium channel inhibitors
|
JP2002518391A
(ja)
|
1998-06-16 |
2002-06-25 |
メルク シャープ エンド ドーム リミテッド |
Gaba受容体のリガンドとしてのトリアゾロ−ピリジン誘導体
|
WO2000012492A1
(en)
|
1998-09-01 |
2000-03-09 |
Nissan Chemical Industries, Ltd. |
Benzoxazine derivatives
|
US6479496B1
(en)
|
1998-09-10 |
2002-11-12 |
Cv Therapeutics, Inc. |
Methods for treating angina with ranolazine
|
US6303607B1
(en)
|
1998-09-10 |
2001-10-16 |
Cv Therapeutics, Inc. |
Method for administering a sustained release ranolanolazine formulation
|
AU6325799A
(en)
|
1998-10-21 |
2000-05-08 |
Dr. Reddy's Research Foundation |
New compounds, their preparation and use
|
US6194458B1
(en)
|
1998-10-30 |
2001-02-27 |
Merck & Co., Inc. |
Benzamide potassium channel inhibitors
|
EP1180514A4
(en)
|
1999-04-09 |
2003-02-26 |
Meiji Seika Kaisha |
NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND BENAMID DERIVATIVES, AND THEIR MEDICINAL PRODUCTS
|
AU4145200A
(en)
|
1999-05-07 |
2000-11-21 |
Takeda Chemical Industries Ltd. |
Cyclic compounds and uses thereof
|
DE19929076A1
(de)
|
1999-06-25 |
2000-12-28 |
Aventis Pharma Gmbh |
Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
|
US6121916A
(en)
|
1999-07-16 |
2000-09-19 |
Eaton-Vorad Technologies, L.L.C. |
Method and apparatus for recognizing stationary objects with a moving side-looking radar
|
CA2381892A1
(en)
|
1999-08-27 |
2001-03-08 |
The Procter & Gamble Company |
Bleach boosting components, compositions and laundry methods
|
CN1382206A
(zh)
|
1999-08-27 |
2002-11-27 |
宝洁公司 |
使用两性离子制剂组分的护色洗涤方法
|
EP1206517A1
(en)
|
1999-08-27 |
2002-05-22 |
The Procter & Gamble Company |
Color safe laundry methods employing cationic formulation components
|
CA2382023A1
(en)
|
1999-08-27 |
2001-03-08 |
The Procter & Gamble Company |
Stable formulation components, compositions and laundry methods employing same
|
MXPA02002129A
(es)
|
1999-08-27 |
2002-09-18 |
Procter & Gamble |
Componentes de formulacion de accion rapida, composiciones y metodos para lavanderia que los emplean.
|
CN1384867A
(zh)
|
1999-08-27 |
2002-12-11 |
宝洁公司 |
稳定性提高的配制组分、使用该组分的组合物和洗衣方法
|
EP1206513A2
(en)
|
1999-08-27 |
2002-05-22 |
The Procter & Gamble Company |
Controlled availability of formulation components, compositions and laundry methods employing same
|
ATE311378T1
(de)
|
1999-09-17 |
2005-12-15 |
Nissan Chemical Ind Ltd |
Benzopyran derivate
|
AU7319800A
(en)
|
1999-09-24 |
2001-04-24 |
Nissan Chemical Industries Ltd. |
4-oxybenzopyran derivative
|
DE19947457A1
(de)
|
1999-10-02 |
2001-04-05 |
Aventis Pharma Gmbh |
2'-Substituierte 1,1'-Biphenyl-2-carbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
|
AU7453900A
(en)
|
1999-10-05 |
2001-05-10 |
Nissan Chemical Industries Ltd. |
4-oxybenzopyran derivative
|
MY125533A
(en)
|
1999-12-06 |
2006-08-30 |
Bristol Myers Squibb Co |
Heterocyclic dihydropyrimidine compounds
|
JP2003518101A
(ja)
|
1999-12-21 |
2003-06-03 |
アイカゲン インコーポレイテッド |
カリウムチャネル阻害剤
|
JP2003533525A
(ja)
|
2000-05-15 |
2003-11-11 |
ダーウィン・ディスカバリー・リミテッド |
Mmpおよびtnf阻害活性を有するヒドロキサム酸およびカルボン酸誘導体
|
KR20030017660A
(ko)
|
2000-08-01 |
2003-03-03 |
오노 야꾸힝 고교 가부시키가이샤 |
3,4-디히드로이소퀴놀린 유도체 화합물 및 그 화합물을유효 성분으로 하는 약제
|
JP2004521079A
(ja)
|
2000-08-29 |
2004-07-15 |
ファルマシア・コーポレーション |
アルファーvベータ3アンタゴニストとして有用な二環式環系を含有する化合物
|
EP1322619B1
(en)
|
2000-09-20 |
2008-01-23 |
Merck & Co., Inc. |
Isoquinolinone potassium channel inhibitors
|
JP2002205992A
(ja)
|
2000-11-08 |
2002-07-23 |
Takeda Chem Ind Ltd |
二環式トリアゾロン誘導体およびそれを含有する除草剤
|
DE10059418A1
(de)
|
2000-11-30 |
2002-06-20 |
Aventis Pharma Gmbh |
Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
|
DE10060807A1
(de)
|
2000-12-07 |
2002-06-20 |
Aventis Pharma Gmbh |
Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
|
DE10061876A1
(de)
|
2000-12-12 |
2002-06-20 |
Aventis Pharma Gmbh |
Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
|
EP1695716A2
(en)
|
2000-12-26 |
2006-08-30 |
Sankyo Company, Limited |
Medicinal compositions containing diuretics and insulin sensitizers
|
TW589305B
(en)
|
2001-02-14 |
2004-06-01 |
Nissan Chemical Ind Ltd |
4-aminobenzopyran derivatives
|
CZ20032185A3
(en)
|
2001-03-09 |
2004-06-16 |
Pfizer Products Inc. |
Triazolopyridines as anti-inflammatory agents
|
US6998408B2
(en)
|
2001-03-23 |
2006-02-14 |
Bristol-Myers Squibb Pharma Company |
6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors
|
DE10121002A1
(de)
|
2001-04-28 |
2002-11-14 |
Aventis Pharma Gmbh |
Verwendung von Anthranilsäureamiden als Medikament zur Behandlung von Arrhythmien sowie sie enthaltende pharmazeutische Zubereitungen
|
DE10121003A1
(de)
|
2001-04-28 |
2002-12-19 |
Aventis Pharma Gmbh |
Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
|
US20030114448A1
(en)
|
2001-05-31 |
2003-06-19 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
DE10128331A1
(de)
|
2001-06-12 |
2002-12-19 |
Aventis Pharma Gmbh |
Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
|
NZ529916A
(en)
|
2001-06-25 |
2005-04-29 |
Nissan Chemical Ind Ltd |
Substituted benzopyran derivatives against arrhythmia
|
JP2005089298A
(ja)
|
2001-09-18 |
2005-04-07 |
Japan Tobacco Inc |
ナフタレン化合物及びその医薬用途
|
GB0124627D0
(en)
|
2001-10-15 |
2001-12-05 |
Smithkline Beecham Plc |
Novel compounds
|
CA2466465A1
(en)
|
2001-11-13 |
2003-05-22 |
Schering Corporation |
Nk1 antagonists
|
TW200307539A
(en)
|
2002-02-01 |
2003-12-16 |
Bristol Myers Squibb Co |
Cycloalkyl inhibitors of potassium channel function
|
US7196108B2
(en)
|
2002-03-08 |
2007-03-27 |
Incyte San Diego Inc. |
Bicyclic heterocycles for the treatment of diabetes and other diseases
|
JP2003277384A
(ja)
|
2002-03-26 |
2003-10-02 |
Kyorin Pharmaceut Co Ltd |
縮合ニ環式ピリジン誘導体
|
JP2003321461A
(ja)
|
2002-04-25 |
2003-11-11 |
Kyorin Pharmaceut Co Ltd |
縮合ビフェニル誘導体
|
MXPA05001785A
(es)
|
2002-08-13 |
2005-04-25 |
Warner Lambert Co |
Derivados de cromona como inhibidores de las metaloproteinasas de matriz.
|
JP2006504665A
(ja)
|
2002-08-13 |
2006-02-09 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
マトリックスメタロプロテイナーゼ阻害剤としてのアザイソキノリン誘導体
|
DE10238865A1
(de)
|
2002-08-24 |
2004-03-11 |
Boehringer Ingelheim International Gmbh |
Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
US20040242572A1
(en)
|
2002-08-24 |
2004-12-02 |
Boehringer Ingelheim International Gmbh |
New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
|
US7005523B2
(en)
|
2002-08-30 |
2006-02-28 |
Pfizer Inc. |
Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines
|
PA8579601A1
(es)
|
2002-08-30 |
2004-05-07 |
Pfizer Prod Inc |
Compuestos antiinflamatorios de di y trifloruro-triazolo-piridinas
|
AU2003262073A1
(en)
|
2002-09-20 |
2004-04-08 |
Tsumura And Co. |
Antitussives
|
US20040204404A1
(en)
|
2002-09-30 |
2004-10-14 |
Robert Zelle |
Human N-type calcium channel blockers
|
GB0223730D0
(en)
|
2002-10-11 |
2002-11-20 |
Novartis Ag |
Organic compounds
|
AU2003285946A1
(en)
|
2002-10-22 |
2004-05-13 |
The Trustees Of The University Of Pennsylvania |
Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases
|
BR0315796A
(pt)
|
2002-11-07 |
2005-09-13 |
Merck & Co Inc |
Composto, composição farmacêutica, e, métodos para tratar diabetes, para tratar hiperglicemia, e para tratar obesidade em um mamìfero
|
CN100430386C
(zh)
|
2002-11-07 |
2008-11-05 |
默克公司 |
苯丙氨酸衍生物作为二肽基肽酶抑制剂用于治疗或预防糖尿病
|
NZ540468A
(en)
|
2003-01-13 |
2008-03-28 |
Univ California |
Method of treating cognitive decline due to sleep deprivation and stress using an AMPA receptor potentiator
|
AR044503A1
(es)
|
2003-03-18 |
2005-09-14 |
Merck & Co Inc |
Triazoles sustituidos con biarilo como bloqueantes del canal de sodio
|
DE10317526A1
(de)
|
2003-04-16 |
2004-11-04 |
Degussa Ag |
Verfahren zum Delignifizieren von ligninhaltigen Faserstoffen
|
EP1622916A4
(en)
|
2003-04-17 |
2008-11-05 |
Merck & Co Inc |
Heterocyclic CYCLOPENTYLTETRAHYDROISOCHINOLINE AND TETRAHYDROPYRIDOPYRIDINE MODULATORS OF CHEMOKIN RECEPTOR ACTIVITY
|
MXPA05010174A
(es)
|
2003-04-25 |
2005-11-08 |
Lundbeck & Co As H |
Derivados de indol e indolina sustituidos.
|
WO2004101509A2
(en)
|
2003-05-06 |
2004-11-25 |
Case Western Reserve University |
Functionalized benzoxazines, polymers and copolymers thereof
|
US7060698B2
(en)
*
|
2003-05-19 |
2006-06-13 |
Hoffmann-La Roche Inc. |
Benzoxazepinone derivatives
|
GB0315950D0
(en)
|
2003-06-11 |
2003-08-13 |
Xention Discovery Ltd |
Compounds
|
CN1823071B
(zh)
|
2003-06-11 |
2012-12-19 |
润生有限公司 |
用作钾通道抑制剂的噻吩并嘧啶衍生物
|
CA2530081A1
(en)
|
2003-07-01 |
2005-01-13 |
Merck & Co., Inc. |
Ophthalmic compositions for treating ocular hypertension
|
MXPA06000796A
(es)
|
2003-07-21 |
2006-04-07 |
Solvay Pharm Gmbh |
Uso de los compuestos 3,7-diazabiciclo [3,3,1]nonano para el tratamiento y/o profilaxis de eventos antiarritmicos en pacientes humanos varones.
|
EP1663994B1
(en)
|
2003-08-05 |
2012-03-07 |
Vertex Pharmaceuticals Incorporated |
Tetrahydroquinazoline compounds as inhibitors of voltage-gated ion channels
|
DE10348298A1
(de)
|
2003-10-17 |
2005-05-19 |
Solvay Pharmaceuticals Gmbh |
Amidomethyl-substituierte 2-(4-Sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-ylderivade, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
US20050239767A1
(en)
|
2003-10-28 |
2005-10-27 |
Chan Michael K |
Intermolecular SNAr of the heterocycle-activated nitro and fluoro groups-application in the synthesis of polyazamacrocyclic ligands
|
TW200514582A
(en)
|
2003-10-31 |
2005-05-01 |
Hisamitsu Pharmaceutical Co |
Transdermal preparation and method for reducing side effect in pergolide therapy
|
CA2550064A1
(en)
|
2003-12-18 |
2005-07-07 |
Pfizer Products Inc. |
Methods of treating acute inflammation in animals with p38 map kinase inhibitors
|
ES2526614T3
(es)
|
2004-03-05 |
2015-01-13 |
Nissan Chemical Industries, Ltd. |
Compuesto de benzamida sustituida con isoxazolina y agente de control de organismos nocivos
|
US7306631B2
(en)
|
2004-03-30 |
2007-12-11 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
BRPI0511917A
(pt)
|
2004-06-10 |
2008-01-15 |
Xention Discovery Ltd |
composto ou sais farmaceuticamente aceitáveis do mesmo, processo para preparar um composto, composição farmacêutica, método para tratar ou prevenir um distúrbio que requer a inibição do canal de potássio, e, uso de um composto
|
GB0412986D0
(en)
|
2004-06-10 |
2004-07-14 |
Xention Discovery Ltd |
Compounds
|
WO2006002470A1
(en)
|
2004-06-30 |
2006-01-12 |
Monash University |
Chiral ligands for asymmetric catalysis
|
JP2006063064A
(ja)
|
2004-07-27 |
2006-03-09 |
Takeda Chem Ind Ltd |
受容体作動剤
|
JP2007297283A
(ja)
|
2004-07-28 |
2007-11-15 |
Santen Pharmaceut Co Ltd |
新規桂皮酸関連化合物
|
CA2577060A1
(en)
|
2004-08-13 |
2006-02-23 |
Amgen Inc. |
Substituted benzofused heterocycles
|
US7521457B2
(en)
|
2004-08-20 |
2009-04-21 |
Boehringer Ingelheim International Gmbh |
Pyrimidines as PLK inhibitors
|
US7625888B2
(en)
|
2004-08-23 |
2009-12-01 |
Merck & Co., Inc. |
Fused triazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
EP1794146B1
(en)
|
2004-09-13 |
2011-08-03 |
Merck Sharp & Dohme Corp. |
Tricyclic anilide spirohydantoin cgrp receptor antagonists
|
AR050948A1
(es)
|
2004-09-24 |
2006-12-06 |
Hoffmann La Roche |
Derivados de ftalazinona; su obtencion y su utilizacion en la fabricacion de medicamentos para el tratamiento del cancer.
|
WO2006047849A1
(en)
|
2004-11-01 |
2006-05-11 |
Institut De Cardiologie De Montreal |
Methods of identifying compounds that regulate acetylcholine-dependent potassium current in cardiac cells for treating atrial fibrillation.
|
WO2006048727A1
(en)
|
2004-11-02 |
2006-05-11 |
Pfizer Products Inc. |
Piperazinylphenalkyl lactam/amine ligands for the 5ht1b receptor
|
JP2006203875A
(ja)
|
2004-12-24 |
2006-08-03 |
Matsushita Electric Ind Co Ltd |
受信装置
|
US7579348B2
(en)
|
2005-02-25 |
2009-08-25 |
Pgxhealth, Llc |
Derivatives of 8-substituted xanthines
|
KR100609101B1
(ko)
|
2005-03-11 |
2006-08-08 |
주식회사 신화성물산 |
물수건 공급장치의 물 분사노즐 및 그 제조방법
|
TW200643015A
(en)
|
2005-03-11 |
2006-12-16 |
Akzo Nobel Nv |
2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives
|
US7714150B2
(en)
|
2005-04-12 |
2010-05-11 |
Solvay Pharmaceuticals Gmbh |
Aminoalkyl-amidomethyl-substituted 2-(4-sulphonylamino)-3-hydroxy-3,4-dihydro-2H-chroman-6-yl derivatives
|
EP1871758B1
(en)
|
2005-04-12 |
2010-08-25 |
Abbott Products GmbH |
Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers
|
EP1874753A2
(en)
|
2005-04-14 |
2008-01-09 |
Smithkline Beecham Corporation |
Compounds, compositions and methods
|
AR056317A1
(es)
|
2005-04-20 |
2007-10-03 |
Xenon Pharmaceuticals Inc |
Compuestos de oxindol y composicion farmaceutica
|
JP5794721B2
(ja)
|
2005-05-17 |
2015-10-14 |
サーコード バイオサイエンス インコーポレイテッド |
眼障害の治療のための組成物および方法
|
TW200714597A
(en)
|
2005-05-27 |
2007-04-16 |
Astrazeneca Ab |
Chemical compounds
|
US7572807B2
(en)
|
2005-06-09 |
2009-08-11 |
Bristol-Myers Squibb Company |
Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
|
BRPI0611948A2
(pt)
|
2005-06-17 |
2010-10-13 |
Wyeth Corp |
compostos úteis como inibidores de serotonina e agonistas de antagonista de 5-ht1a
|
TW200726765A
(en)
|
2005-06-17 |
2007-07-16 |
Bristol Myers Squibb Co |
Triazolopyridine cannabinoid receptor 1 antagonists
|
US7632837B2
(en)
|
2005-06-17 |
2009-12-15 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoid-1 receptor modulators
|
WO2007004028A2
(en)
|
2005-06-30 |
2007-01-11 |
Ranbaxy Laboratories Limited |
Processes for the preparation of penems and its intermediate
|
WO2007004960A1
(en)
*
|
2005-07-05 |
2007-01-11 |
Astrazeneca Ab |
New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer’s desease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson’s disease
|
GB0516963D0
(en)
|
2005-08-18 |
2005-09-28 |
Carbonite Corp |
Liquid dispensers
|
EP1932549B1
(en)
|
2005-08-26 |
2016-12-28 |
AMNOS Co., Ltd. |
Dried amnion and method for drying treatment of amnion
|
JP2009508963A
(ja)
|
2005-09-21 |
2009-03-05 |
インサイト・コーポレイション |
アミド化合物および医薬組成物としてのその使用
|
MX2008004024A
(es)
|
2005-09-23 |
2009-02-27 |
Schering Corp |
Antagonistas de receptor de glutamato metabotropico-1 tetraciclicos fusionados como agentes terapeuticos.
|
US20090022694A1
(en)
|
2005-10-18 |
2009-01-22 |
Distefano Peter |
Sirt1 inhibition
|
TW200804290A
(en)
|
2005-11-15 |
2008-01-16 |
Astrazeneca Ab |
Compounds and uses thereof
|
CA2629457A1
(en)
|
2005-11-18 |
2007-05-31 |
Merck & Co., Inc. |
Spirolactam bicyclic cgrp receptor antagonists
|
US7851464B2
(en)
|
2005-11-18 |
2010-12-14 |
Merck Sharp & Dohme Corp. |
Spirolactam aryl CGRP receptor antagonists
|
GB0525164D0
(en)
|
2005-12-09 |
2006-01-18 |
Xention Discovery Ltd |
Compounds
|
TW200734342A
(en)
|
2005-12-15 |
2007-09-16 |
Astrazeneca Ab |
New compounds for the treatment of cardiac arrhythmias
|
WO2007070866A2
(en)
|
2005-12-16 |
2007-06-21 |
Alcon, Inc. |
Control of intraocular pressure using alk5 modulation agents
|
US8013073B2
(en)
|
2005-12-30 |
2011-09-06 |
Chevron Oronite Company Llc |
Method for preparing polyolefins containing vinylidine end groups using nonaromatic heterocyclic compounds
|
US8110681B2
(en)
|
2006-03-17 |
2012-02-07 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Compounds for the treatment of spinal muscular atrophy and other uses
|
MX2008012617A
(es)
|
2006-03-31 |
2008-10-10 |
Novartis Ag |
Compuestos organicos.
|
EP2018863B9
(en)
|
2006-05-16 |
2015-02-18 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound and use thereof
|
EP2043654A2
(en)
|
2006-06-12 |
2009-04-08 |
Vertex Pharmaceuticals, Inc. |
Thienopyrimidines useful as modulators of ion channels
|
EP2035372A1
(en)
|
2006-06-29 |
2009-03-18 |
Arena Pharmaceuticals, Inc. |
Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
|
WO2008005457A2
(en)
|
2006-06-30 |
2008-01-10 |
Sunesis Pharmaceuticals |
Pyridinonyl pdk1 inhibitors
|
US20090318412A1
(en)
|
2006-07-11 |
2009-12-24 |
Takahiro Matsumoto |
Tricyclic heterocyclic compound and use thereof
|
AU2007272009A1
(en)
|
2006-07-12 |
2008-01-17 |
Syngenta Limited |
Triazolopyridine derivatives as herbicides
|
PE20080403A1
(es)
|
2006-07-14 |
2008-04-25 |
Amgen Inc |
Derivados heterociclicos fusionados y metodos de uso
|
US8217177B2
(en)
|
2006-07-14 |
2012-07-10 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
CA2661299A1
(en)
|
2006-08-22 |
2008-02-28 |
Ranbaxy Laboratories Limited |
Beta -hydroxy-and amino-substituted carboxylic acids as matrix metalloproteinase inhibitors
|
EP2068869A4
(en)
|
2006-10-06 |
2011-05-25 |
Abbott Lab |
NEW IMIDAZOTHIAZOLE AND IMIDAZOXAZOLE
|
BRPI0719166A2
(pt)
*
|
2006-10-12 |
2014-06-03 |
Xenon Pharmaceuticals Inc |
Derivados de espiro-oxindol tricíclicos e seus usos como agentes terapêuticos
|
WO2008118141A2
(en)
|
2006-10-17 |
2008-10-02 |
Acadia Pharmaceuticals Inc. |
Use of cannabinoid modulating compounds in combination with other therapeutic compounds for adjunctive therapy
|
EP2222647B1
(en)
|
2006-10-23 |
2015-08-05 |
Cephalon, Inc. |
Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and c-met inhibitors
|
CN103275067B
(zh)
|
2006-10-28 |
2015-09-02 |
梅特希尔基因公司 |
组蛋白脱乙酰酶抑制剂
|
JPWO2008053913A1
(ja)
|
2006-11-02 |
2010-02-25 |
塩野義製薬株式会社 |
Mmp−13を選択的に阻害するスルホニルウレア誘導体
|
JP2010514696A
(ja)
|
2006-12-21 |
2010-05-06 |
ギリアード・パロ・アルト・インコーポレイテッド |
心血管症状の低減
|
US8076350B2
(en)
|
2006-12-22 |
2011-12-13 |
Abbott Laboratories |
Spirocyclic azaadamantane derivatives and methods of use
|
AR065081A1
(es)
|
2007-01-29 |
2009-05-13 |
Xenon Pharmaceuticals Inc |
Compuestos de quinazolinona y pirimidona fusionados y composicion farmaceutica
|
AU2008219723A1
(en)
|
2007-02-28 |
2008-09-04 |
Merck Sharp & Dohme Corp. |
Substituted benzodiazepinones, benzoxazepinones and benzothiazepinones as sodium channel blockers
|
WO2008108445A1
(ja)
|
2007-03-07 |
2008-09-12 |
Takeda Pharmaceutical Company Limited |
ベンゾオキサゼピン誘導体およびその用途
|
GB0706072D0
(en)
|
2007-03-28 |
2007-05-09 |
Sterix Ltd |
Compound
|
KR20100015685A
(ko)
|
2007-04-12 |
2010-02-12 |
씨브이 쎄러퓨틱스, 인코포레이티드 |
인슐린 분비 강화를 위한 라놀라진
|
WO2008134553A1
(en)
|
2007-04-26 |
2008-11-06 |
Xenon Pharmaceuticals Inc. |
Methods of using bicyclic compounds in treating sodium channel-mediated diseases
|
WO2008144483A2
(en)
*
|
2007-05-18 |
2008-11-27 |
Armgo Pharma, Inc. |
Agents for treating disorders involving modulation of ryanodine receptors
|
WO2009005675A1
(en)
|
2007-06-28 |
2009-01-08 |
Abbott Laboratories |
Novel triazolopyridazines
|
US20090012103A1
(en)
|
2007-07-05 |
2009-01-08 |
Matthew Abelman |
Substituted heterocyclic compounds
|
US20090181986A1
(en)
|
2007-07-05 |
2009-07-16 |
Matthew Abelman |
Substituted heterocyclic compounds
|
US20090036425A1
(en)
|
2007-08-02 |
2009-02-05 |
Pfizer Inc |
Substituted bicyclolactam compounds
|
WO2009026444A1
(en)
|
2007-08-22 |
2009-02-26 |
President And Fellows Of Harvard College |
Ryanodine channel binders and uses thereof
|
AP2010005202A0
(en)
|
2007-09-12 |
2010-04-30 |
Wyeth Llc |
Isoquinolinyl and isoindolinyl derivatives as histamines-3 antagonists
|
US8119658B2
(en)
|
2007-10-01 |
2012-02-21 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
AU2008343062B2
(en)
|
2007-12-19 |
2013-03-07 |
Genentech, Inc. |
8-Anilinoimidazopyridines and their use as anti-cancer and/or anti-inflammatory agents
|
BRPI0821394A2
(pt)
|
2007-12-19 |
2015-06-16 |
Wyeth Llc |
4-imidazolidinonas como inibidores de canal de potássio kv1.5
|
AU2008338368A1
(en)
|
2007-12-19 |
2009-06-25 |
Wyeth Llc |
4-imidazolidinones as Kv1.5 potassium channel inhibitors
|
PE20091339A1
(es)
|
2007-12-21 |
2009-09-26 |
Glaxo Group Ltd |
Derivados de oxadiazol con actividad sobre receptores s1p1
|
EP2231669A1
(en)
|
2008-01-09 |
2010-09-29 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Phosphodiesterase inhibitors
|
EA201070914A1
(ru)
|
2008-02-06 |
2011-04-29 |
Гайлид Сайэнсиз, Инк. |
Применение ранолазина для лечения боли
|
JPWO2009101917A1
(ja)
|
2008-02-13 |
2011-06-09 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ビシクロアミン誘導体
|
JP2009286773A
(ja)
|
2008-03-14 |
2009-12-10 |
Bayer Cropscience Ag |
殺虫性縮環式アリール類
|
WO2009137462A2
(en)
|
2008-05-05 |
2009-11-12 |
Envivo Pharmaceuticals, Inc. |
Methods for treating cognitive disorders using inhibitors of histone deacetylase
|
WO2009137499A1
(en)
|
2008-05-05 |
2009-11-12 |
Envivo Pharmaceuticals, Inc. |
Inhibitors of histone deacetylase
|
DE102008024182A1
(de)
|
2008-05-19 |
2009-11-26 |
Merck Patent Gmbh |
Verbindungen für organische elektronische Vorrichtung
|
WO2009148452A1
(en)
|
2008-06-06 |
2009-12-10 |
Abbott Laboratories |
Novel 1,2,4 oxadiazole compounds and methods of use thereof
|
CN102124000B
(zh)
|
2008-06-17 |
2014-09-17 |
阿斯利康(瑞典)有限公司 |
吡啶化合物
|
US8338477B2
(en)
|
2008-07-11 |
2012-12-25 |
Neumedics |
Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
|
MY147281A
(en)
|
2008-07-31 |
2012-11-30 |
Invenpro M Sdn Bhd |
An apparatus for washing a workpiece
|
AU2009277232B2
(en)
|
2008-07-31 |
2012-03-29 |
Poh Huay Chua |
Pet carrier
|
KR101315628B1
(ko)
|
2008-08-12 |
2013-10-08 |
닛뽕소다 가부시키가이샤 |
함질소 헤테로고리 유도체 및 농원예용 살균제
|
WO2010022001A1
(en)
|
2008-08-18 |
2010-02-25 |
Im&T Research, Inc. |
Methods for preparing fluoroalkyl arylsulfinyl compounds and fluorinated compounds thereto
|
GB0815781D0
(en)
|
2008-08-29 |
2008-10-08 |
Xention Ltd |
Novel potassium channel blockers
|
GB0815782D0
(en)
|
2008-08-29 |
2008-10-08 |
Xention Ltd |
Novel potassium channel blockers
|
GB0815784D0
(en)
|
2008-08-29 |
2008-10-08 |
Xention Ltd |
Novel potassium channel blockers
|
US20100056536A1
(en)
|
2008-09-04 |
2010-03-04 |
Charles Antzelevitch |
Method of treating atrial fibrillation
|
US20100113461A1
(en)
|
2008-10-29 |
2010-05-06 |
Gilead Palo Alto, Inc. |
Substituted heterocyclic compounds
|
US8389500B2
(en)
|
2008-10-30 |
2013-03-05 |
Gilead Sciences, Inc. |
Fused heterocyclic compounds as ion channel modulators
|
WO2010074807A1
(en)
|
2008-10-30 |
2010-07-01 |
Gilead Palo Alto, Inc. |
3, 4-dihydroquinolin-2 ( 1h ) -one derivatives as sodium channel modulators
|
WO2010056865A1
(en)
|
2008-11-14 |
2010-05-20 |
Gilead Palo Alto, Inc. |
Quinoline derivatives as ion channel modulators
|
WO2010068461A1
(en)
|
2008-11-25 |
2010-06-17 |
Gilead Palo Alto, Inc. |
Co-administration of ranolazine and cardiac glycosides
|
MX2011005597A
(es)
|
2008-12-05 |
2011-06-16 |
Hoffmann La Roche |
Pirrolopirazinil-ureas como inhibidores de cinasas.
|
KR20110098789A
(ko)
|
2008-12-08 |
2011-09-01 |
서트리스 파마슈티컬즈, 인코포레이티드 |
시르투인 조절제로서의 이소인돌리논 및 관련 유사체
|
BRPI0922224A2
(pt)
|
2008-12-08 |
2016-08-02 |
Vm Pharma Llc |
composições de inibidores de proteína tirosina quiinase receptora.
|
JP5271069B2
(ja)
|
2008-12-24 |
2013-08-21 |
三和シヤッター工業株式会社 |
開閉装置
|
FR2943342B1
(fr)
|
2009-03-20 |
2011-03-04 |
Servier Lab |
Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
|
US9150554B2
(en)
|
2009-03-27 |
2015-10-06 |
Presidio Pharmaceuticals, Inc. |
Fused ring inhibitors of hepatitis C
|
US20100305093A1
(en)
*
|
2009-04-09 |
2010-12-02 |
Exelixis, Inc. |
Inhibitors of mTOR and Methods of Making and Using
|
RS56410B1
(sr)
|
2009-07-27 |
2018-01-31 |
Gilead Sciences Inc |
Fuzionisana heterociklična jedinjenja kao modulatori jonskih kanala
|
US8242104B2
(en)
*
|
2009-09-28 |
2012-08-14 |
F. Hoffman-La Roche Ag |
Benzoxazepin P13K inhibitor compounds and methods of use
|
WO2011042920A1
(en)
|
2009-10-07 |
2011-04-14 |
Decode Genetics Ehf |
Genetic variants indicative of vascular conditions
|
WO2011056985A2
(en)
*
|
2009-11-04 |
2011-05-12 |
Gilead Sciences, Inc. |
Substituted heterocyclic compounds
|
WO2011075607A1
(en)
|
2009-12-18 |
2011-06-23 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
TWI508726B
(zh)
|
2009-12-21 |
2015-11-21 |
Gilead Sciences Inc |
治療心房纖維性顫動之方法
|
US8323911B2
(en)
|
2010-05-13 |
2012-12-04 |
University Of South Carolina |
High throughput assay for discovering new inhibitors of the GIRK1/4 channel
|
BR112012033402A2
(pt)
|
2010-07-02 |
2017-01-24 |
Gilead Sciences Inc |
moduladores de canais de íons conforme os compostos heterocíclicos fundidos
|
WO2012019076A1
(en)
|
2010-08-06 |
2012-02-09 |
The Trustees Of Columbia University In The City Of New York |
Compositions and methods for preventing and treating cardiac ischemia/reperfusion injury
|
WO2012019071A1
(en)
|
2010-08-06 |
2012-02-09 |
The Trustees Of Columbia University In The City Of New York |
Methods of preventing and treating sarcopenia
|
WO2012037105A1
(en)
|
2010-09-14 |
2012-03-22 |
The Trustees Of Columbia University In The City Of New York |
Methods of treating, ameliorating or preventing stress-induced neuronal disorders and diseases
|
WO2012036233A1
(ja)
|
2010-09-17 |
2012-03-22 |
塩野義製薬株式会社 |
メラニン凝集ホルモン受容体アンタゴニスト活性を有する縮合へテロ環誘導体
|
ME02367B
(me)
|
2010-09-21 |
2016-06-20 |
Purdue Pharma Lp |
Analozi buprenorfina kao agonisti i/ili antagonisti opioidnog receptora
|
US8999967B2
(en)
|
2010-09-29 |
2015-04-07 |
Presidio Pharmaceuticals, Inc. |
Tricyclic fused ring inhibitors of hepatitis C
|
EP2643316A2
(en)
|
2010-11-24 |
2013-10-02 |
Exelixis, Inc. |
Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
|
WO2012074469A1
(en)
|
2010-11-30 |
2012-06-07 |
Astrazeneca Ab |
New ikach blockers
|
JP5675428B2
(ja)
|
2011-02-25 |
2015-02-25 |
サンドビック株式会社 |
ベルトプレス装置
|
WO2012126901A1
(en)
*
|
2011-03-21 |
2012-09-27 |
F. Hoffmann-La Roche Ag |
Benzoxazepin compounds selective for pi3k p110 delta and methods of use
|
JP5934787B2
(ja)
|
2011-05-10 |
2016-06-15 |
ギリアード サイエンシーズ, インコーポレイテッド |
イオンチャネルモジュレーターとしての縮合複素環式化合物
|
CA2836904C
(en)
|
2011-06-03 |
2019-09-24 |
Signpath Pharma Inc. |
Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current
|
TW201837023A
(zh)
|
2011-07-01 |
2018-10-16 |
美商基利科學股份有限公司 |
作為離子通道調節劑之稠合雜環化合物
|
SG195100A1
(en)
|
2011-07-01 |
2013-12-30 |
Bayer Ip Gmbh |
Hydroxymethylaryl-substituted pyrrolotriazines as alk1 inhibitors
|
TWI567061B
(zh)
|
2011-07-01 |
2017-01-21 |
吉李德科學股份有限公司 |
用於治療成癮之化合物
|
NO3175985T3
(es)
*
|
2011-07-01 |
2018-04-28 |
|
|
EP2758053A1
(en)
|
2011-09-21 |
2014-07-30 |
Gilead Sciences, Inc. |
Sodium channel blockers reduce glucagon secretion
|
US8623860B2
(en)
|
2011-12-30 |
2014-01-07 |
Boehringer Ingelheim International Gmbh |
Azetidine derivatives, pharmaceutical compositions and uses thereof
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
WO2013112932A1
(en)
|
2012-01-27 |
2013-08-01 |
Gilead Sciences, Inc. |
Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
|
ES2805341T3
(es)
|
2012-06-13 |
2021-02-11 |
Acesion Pharma Aps |
Composiciones farmacéuticas para terapia de combinación
|
WO2014134419A1
(en)
|
2013-03-01 |
2014-09-04 |
Gilead Sciences, Inc. |
Use of ikach blockers for the treatment of cardiac diseases
|
CN104844535A
(zh)
|
2014-02-13 |
2015-08-19 |
吉利德科学公司 |
用于制备稠合杂环离子通道调节剂的方法
|
TW201613908A
(en)
|
2014-02-13 |
2016-04-16 |
Gilead Sciences Inc |
Solid forms of an ion channel modulator
|